AMEX · Key Statistics

Pelthos Therapeutics Inc. (PTHS) Key Statistics

$17.00 AMEX: PTHS Market Cap $65.08M

Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for Pelthos Therapeutics Inc. (PTHS), each with what it measures. Figures are trailing twelve months or the most recent reported period.

Valuation

Metric	Value
P/E ratioShare price divided by earnings per share.	-0.47
P/B ratioShare price divided by book value per share.	-46.19
P/S ratioMarket value divided by annual revenue.	1.73
PEG ratioP/E divided by the earnings growth rate.	0.00
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.	-1.97
EV / RevenueEnterprise value against annual revenue.	2.85
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.	-208.33%
Free cash flow yieldFree cash flow as a percentage of market value.	-56.79%

Profitability

Metric	Value
Gross marginRevenue left after the direct cost of goods sold.	54.72%
Operating marginRevenue left after operating costs.	-133.42%
Net marginRevenue left after every cost, including tax and interest.	-165.24%
Return on equityProfit as a percentage of shareholders’ equity.	-218.94%
Return on assetsProfit as a percentage of total assets.	-52.10%
Return on capital employedOperating profit against the capital the business uses.	-54.82%

Financial health

Metric	Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.	1.98
Quick ratioThe same, excluding inventory.	1.31
Cash ratioCash alone against current liabilities.	0.69
Debt to equityTotal borrowings against shareholders’ equity.	-48.71
Debt to assetsTotal borrowings against total assets.	0.27
Interest coverageHow many times operating profit covers the interest bill.	-7.81

Per share and size

Metric	Value
Earnings per shareProfit attributable to each share.	$-23.04
Shares outstandingShares currently issued.	0
Market capitalisationShare price times shares outstanding.	$65.08M
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.	$123.00M
EmployeesReported headcount.	4

Dividend

Metric	Value
Dividend yieldAnnual dividend as a percentage of the share price.	0.00%
Payout ratioShare of profit paid out as dividends.	0.00%

Pelthos Therapeutics Inc. (PTHS) statistics — frequently asked questions

What is Pelthos Therapeutics Inc.'s P/E ratio?

Pelthos Therapeutics Inc. (PTHS) trades on a price-to-earnings ratio of -0.47. A negative P/E means the company reported a loss, so the ratio is not a meaningful valuation measure.

What is Pelthos Therapeutics Inc.'s return on equity?

Pelthos Therapeutics Inc. (PTHS) reports a return on equity of -218.94%, meaning it generated that much profit for every dollar of shareholders' equity.

How much debt does Pelthos Therapeutics Inc. carry?

Pelthos Therapeutics Inc. (PTHS) has a debt-to-equity ratio of -48.71, which compares total borrowings with shareholders' equity.

What is Pelthos Therapeutics Inc.'s profit margin?

Pelthos Therapeutics Inc. (PTHS) keeps -165.24% of revenue as net profit after every cost, including tax and interest.

Related stock screens

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks High ROE Stocks Low P/E Stocks High Net Margin Stocks Dividend Stocks Low Debt Stocks All stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.